[S,S]-Reboxetine Add-On Trial
[S,S]-Reboxetine Add-On Trial
The purpose of this study is to determine the effectiveness of adjunctive treatment of
 pregabalin with [S,S]-Reboxetine against pregabalin monotherapy in patients with PHN
Inclusion Criteria:

 -  Patients must have pain present for more than 3 months after the healing of shingles
 skin rash

 -  Patients at screening must have a score >/=40 mm on the pain visual analogue scale

 Exclusion Criteria:

 -  Patients with significant renal and hepatic impairment

 -  Patients with other severe pain, that may impair the self-assessment of the pain due
 to shingles

 -  Patients with clinically abnormal electrocardiogram